DIARYLACETYLENE HYDRAZIDE CONTAINING TYROSINE KINASE INHIBITORS

The present invention relates to novel diarylacetylene hydrazide compounds of formula (I) or pharmaceutically acceptable salt thereof, as tyrosine kinase inhibitors, the process for their preparation, and to the use of the compounds of formula (I) in the preparation of pharmaceutical compositions fo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: THENNATI, RAJAMANNAR, SENGUPTA, PRABAL, CHITTURI, TRINADHA RAO, PURI, CHETAN SURJITSINGH, DESAI, DIPALI MANUBHAI, CHIMANWALA, SABBIRHUSEN YUSUFBHAI, MEHTA, VARUN ANILKUMAR, CHOKSHI, HEMANT ASHVINBHAI
Format: Patent
Sprache:eng ; spa
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator THENNATI, RAJAMANNAR
SENGUPTA, PRABAL
CHITTURI, TRINADHA RAO
PURI, CHETAN SURJITSINGH
DESAI, DIPALI MANUBHAI
CHIMANWALA, SABBIRHUSEN YUSUFBHAI
MEHTA, VARUN ANILKUMAR
CHOKSHI, HEMANT ASHVINBHAI
description The present invention relates to novel diarylacetylene hydrazide compounds of formula (I) or pharmaceutically acceptable salt thereof, as tyrosine kinase inhibitors, the process for their preparation, and to the use of the compounds of formula (I) in the preparation of pharmaceutical compositions for the therapeutic treatment of disorders related to tyrosine kinases, in warm-blooded animals. La presente invención se relaciona con compuestos de hidrazida diarilacetileno de la formula (I) o una sal farmacéuticamente aceptable del mismo, como los inhibidores de quinasa tirosina, el proceso para su preparación, y para el uso de los compuestos de la formula (I) en la preparación de las composciciones farmacéuticas para el tratamiento terapéutico o trastornos relacionados con las quinasas de tirosina, en animales de sangre caliente.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_MX336051B</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>MX336051B</sourcerecordid><originalsourceid>FETCH-epo_espacenet_MX336051B3</originalsourceid><addsrcrecordid>eNrjZLB38XQMivRxdHYNifRx9XNV8Ih0CXKM8nRxVXD29wtx9PTz9HNXCIkM8g_2BMp6e_o5BrsqePp5eDp5hvgHBfMwsKYl5hSn8kJpbgY5N9cQZw_d1IL8-NTigsTk1LzUknjfCGNjMwNTQydjggoAzwUpzg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>DIARYLACETYLENE HYDRAZIDE CONTAINING TYROSINE KINASE INHIBITORS</title><source>esp@cenet</source><creator>THENNATI, RAJAMANNAR ; SENGUPTA, PRABAL ; CHITTURI, TRINADHA RAO ; PURI, CHETAN SURJITSINGH ; DESAI, DIPALI MANUBHAI ; CHIMANWALA, SABBIRHUSEN YUSUFBHAI ; MEHTA, VARUN ANILKUMAR ; CHOKSHI, HEMANT ASHVINBHAI</creator><creatorcontrib>THENNATI, RAJAMANNAR ; SENGUPTA, PRABAL ; CHITTURI, TRINADHA RAO ; PURI, CHETAN SURJITSINGH ; DESAI, DIPALI MANUBHAI ; CHIMANWALA, SABBIRHUSEN YUSUFBHAI ; MEHTA, VARUN ANILKUMAR ; CHOKSHI, HEMANT ASHVINBHAI</creatorcontrib><description>The present invention relates to novel diarylacetylene hydrazide compounds of formula (I) or pharmaceutically acceptable salt thereof, as tyrosine kinase inhibitors, the process for their preparation, and to the use of the compounds of formula (I) in the preparation of pharmaceutical compositions for the therapeutic treatment of disorders related to tyrosine kinases, in warm-blooded animals. La presente invención se relaciona con compuestos de hidrazida diarilacetileno de la formula (I) o una sal farmacéuticamente aceptable del mismo, como los inhibidores de quinasa tirosina, el proceso para su preparación, y para el uso de los compuestos de la formula (I) en la preparación de las composciciones farmacéuticas para el tratamiento terapéutico o trastornos relacionados con las quinasas de tirosina, en animales de sangre caliente.</description><language>eng ; spa</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2016</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20160107&amp;DB=EPODOC&amp;CC=MX&amp;NR=336051B$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20160107&amp;DB=EPODOC&amp;CC=MX&amp;NR=336051B$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>THENNATI, RAJAMANNAR</creatorcontrib><creatorcontrib>SENGUPTA, PRABAL</creatorcontrib><creatorcontrib>CHITTURI, TRINADHA RAO</creatorcontrib><creatorcontrib>PURI, CHETAN SURJITSINGH</creatorcontrib><creatorcontrib>DESAI, DIPALI MANUBHAI</creatorcontrib><creatorcontrib>CHIMANWALA, SABBIRHUSEN YUSUFBHAI</creatorcontrib><creatorcontrib>MEHTA, VARUN ANILKUMAR</creatorcontrib><creatorcontrib>CHOKSHI, HEMANT ASHVINBHAI</creatorcontrib><title>DIARYLACETYLENE HYDRAZIDE CONTAINING TYROSINE KINASE INHIBITORS</title><description>The present invention relates to novel diarylacetylene hydrazide compounds of formula (I) or pharmaceutically acceptable salt thereof, as tyrosine kinase inhibitors, the process for their preparation, and to the use of the compounds of formula (I) in the preparation of pharmaceutical compositions for the therapeutic treatment of disorders related to tyrosine kinases, in warm-blooded animals. La presente invención se relaciona con compuestos de hidrazida diarilacetileno de la formula (I) o una sal farmacéuticamente aceptable del mismo, como los inhibidores de quinasa tirosina, el proceso para su preparación, y para el uso de los compuestos de la formula (I) en la preparación de las composciciones farmacéuticas para el tratamiento terapéutico o trastornos relacionados con las quinasas de tirosina, en animales de sangre caliente.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2016</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLB38XQMivRxdHYNifRx9XNV8Ih0CXKM8nRxVXD29wtx9PTz9HNXCIkM8g_2BMp6e_o5BrsqePp5eDp5hvgHBfMwsKYl5hSn8kJpbgY5N9cQZw_d1IL8-NTigsTk1LzUknjfCGNjMwNTQydjggoAzwUpzg</recordid><startdate>20160107</startdate><enddate>20160107</enddate><creator>THENNATI, RAJAMANNAR</creator><creator>SENGUPTA, PRABAL</creator><creator>CHITTURI, TRINADHA RAO</creator><creator>PURI, CHETAN SURJITSINGH</creator><creator>DESAI, DIPALI MANUBHAI</creator><creator>CHIMANWALA, SABBIRHUSEN YUSUFBHAI</creator><creator>MEHTA, VARUN ANILKUMAR</creator><creator>CHOKSHI, HEMANT ASHVINBHAI</creator><scope>EVB</scope></search><sort><creationdate>20160107</creationdate><title>DIARYLACETYLENE HYDRAZIDE CONTAINING TYROSINE KINASE INHIBITORS</title><author>THENNATI, RAJAMANNAR ; SENGUPTA, PRABAL ; CHITTURI, TRINADHA RAO ; PURI, CHETAN SURJITSINGH ; DESAI, DIPALI MANUBHAI ; CHIMANWALA, SABBIRHUSEN YUSUFBHAI ; MEHTA, VARUN ANILKUMAR ; CHOKSHI, HEMANT ASHVINBHAI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_MX336051B3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; spa</language><creationdate>2016</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>THENNATI, RAJAMANNAR</creatorcontrib><creatorcontrib>SENGUPTA, PRABAL</creatorcontrib><creatorcontrib>CHITTURI, TRINADHA RAO</creatorcontrib><creatorcontrib>PURI, CHETAN SURJITSINGH</creatorcontrib><creatorcontrib>DESAI, DIPALI MANUBHAI</creatorcontrib><creatorcontrib>CHIMANWALA, SABBIRHUSEN YUSUFBHAI</creatorcontrib><creatorcontrib>MEHTA, VARUN ANILKUMAR</creatorcontrib><creatorcontrib>CHOKSHI, HEMANT ASHVINBHAI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>THENNATI, RAJAMANNAR</au><au>SENGUPTA, PRABAL</au><au>CHITTURI, TRINADHA RAO</au><au>PURI, CHETAN SURJITSINGH</au><au>DESAI, DIPALI MANUBHAI</au><au>CHIMANWALA, SABBIRHUSEN YUSUFBHAI</au><au>MEHTA, VARUN ANILKUMAR</au><au>CHOKSHI, HEMANT ASHVINBHAI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>DIARYLACETYLENE HYDRAZIDE CONTAINING TYROSINE KINASE INHIBITORS</title><date>2016-01-07</date><risdate>2016</risdate><abstract>The present invention relates to novel diarylacetylene hydrazide compounds of formula (I) or pharmaceutically acceptable salt thereof, as tyrosine kinase inhibitors, the process for their preparation, and to the use of the compounds of formula (I) in the preparation of pharmaceutical compositions for the therapeutic treatment of disorders related to tyrosine kinases, in warm-blooded animals. La presente invención se relaciona con compuestos de hidrazida diarilacetileno de la formula (I) o una sal farmacéuticamente aceptable del mismo, como los inhibidores de quinasa tirosina, el proceso para su preparación, y para el uso de los compuestos de la formula (I) en la preparación de las composciciones farmacéuticas para el tratamiento terapéutico o trastornos relacionados con las quinasas de tirosina, en animales de sangre caliente.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; spa
recordid cdi_epo_espacenet_MX336051B
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title DIARYLACETYLENE HYDRAZIDE CONTAINING TYROSINE KINASE INHIBITORS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T22%3A48%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=THENNATI,%20RAJAMANNAR&rft.date=2016-01-07&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EMX336051B%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true